Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2023 | 04-2023 | 01-2023 | 10-2022 | 07-2022 | |
| Sales | 0 | 210 | 0 | 0 | 0 |
| Gross Profit | N/A | 210 | N/A | N/A | N/A |
| Operating Expenses | 2,844 | 2,770 | 2,556 | 3,609 | 2,797 |
| Operating Income | -2,844 | -2,560 | -2,556 | -3,609 | -2,797 |
| Other Income | 296 | 253 | 202 | 80 | 22 |
| Pre-tax Income | -2,548 | -2,307 | -2,354 | -3,529 | -2,775 |
| Net Income Continuous | -2,548 | -2,307 | -2,354 | -3,529 | -2,775 |
| Minority Interests | -37 | -19 | -32 | -53 | -29 |
| Net Income | $-2,511 | $-2,288 | $-2,322 | $-3,476 | $-2,746 |
| EPS Basic Total Ops | -0.08 | -0.07 | -0.08 | -0.11 | -0.09 |
| EPS Basic Continuous Ops | -0.08 | -0.07 | -0.08 | -0.11 | -0.09 |
| EPS Diluted Total Ops | -0.08 | -0.07 | -0.08 | -0.11 | -0.09 |
| EPS Diluted Continuous Ops | -0.08 | -0.07 | -0.08 | -0.11 | -0.09 |
| EBITDA(a) | $-2,833 | $-2,548 | $-2,545 | $-3,598 | $-2,787 |